Full-Time
Direct-to-consumer DNA testing services
$160k - $240k/yr
Senior
Sunnyvale, CA, USA
Requires onsite presence in Sunnyvale, CA for a minimum of 3 days per week.
Upload your resume to see how it matches 4 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
23andMe offers direct-to-consumer DNA testing that provides individuals with insights into their ancestry, genetic traits, and potential health risks. Customers purchase a DNA testing kit, send in a saliva sample, and receive personalized genetic reports based on the analysis of their DNA. This service appeals to a wide range of people, from those curious about their family history to those wanting to understand their health predispositions. Unlike many competitors, 23andMe not only sells these kits but also offers subscription services for ongoing updates and insights based on new genetic research. Additionally, the company utilizes its large genetic database for research collaborations, which can lead to further revenue through partnerships with research institutions and pharmaceutical companies. The goal of 23andMe is to empower individuals with knowledge about their genetics while contributing to advancements in genetic research.
Company Size
501-1,000
Company Stage
IPO
Headquarters
Sunnyvale, California
Founded
2006
Help us improve and share your feedback! Did you find this helpful?
Comprehensive health, vision, & dental plans
Family planning, support, & leave for parents
Mental healthcare
Student loan assistance
Volunteer time off
Dog friendly office
Genetic testing company 23andMe is seeking a new owner as part of its Chapter 11 bankruptcy protection proceedings.
The genetic testing company 23andMe, once a pioneer in consumer DNA testing, has filed for Chapter 11 bankruptcy amid financial struggles, a leadership shakeup and growing concerns about the security of its customers' genetic data.
23andMe announced Joe Selsavage, its chief financial and accounting officer, has been named interim CEO.
What You Should Know: – 23andMe, a human genetics and biotechnology company, has announced its decision to initiate voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri. – The bankruptcy filing is aimed at facilitating a structured sale process to maximize the value of its business. The company has assured its customers that operations will continue as normal and that there will be no changes to the way customer data is stored, managed, or protected.Chapter 11 Details23andMe is seeking court authorization to conduct a sale of substantially all its assets, either through a Chapter 11 plan or under Section 363 of the U.S. Bankruptcy Code. Upon court approval, the company, with the assistance of an independent investment banker, will actively solicit qualified bids over a 45-day period. If multiple bids are received, an auction will be held to ensure the highest possible value is obtained. To ensure continued operations during the proceedings, 23andMe has filed customary “first-day” motions, seeking court approval to pay employee wages and benefits, and compensate essential vendors and suppliers
On Sunday, the genetic testing and heritage company 23andMe announced that it had entered Chapter 11 bankruptcy and was asking a court to arrange its sale.